Most Genetic Risk for Drug Abuse Is Shared Across Substances, Not Drug-Specific | Research

The takeaway

A large Swedish twin and sibling study found that 75-90% of genetic risk for cannabis, stimulant, and sedative abuse comes from a shared vulnerability to substance use in general, not from drug-specific genes.

Read this if you are curious about whether addiction runs in families and whether the risk is specific to certain substances.

75-90% of genetic risk for drug abuse is shared, not substance-specific

What the researchers found

Researchers analyzed registry data from nearly 80,000 Swedish male twin and sibling pairs to understand whether genetic risk for drug abuse is substance-specific or shared across drug types.

The total heritability for cannabis, stimulant, and sedative abuse ranged from 64-70%. Of that genetic risk, 75-90% was non-specific, meaning the same genetic factors influenced vulnerability to all three substance types.

All shared environmental effects (18-20% of variance) were also non-specific. This suggests that genetic variation at the specific brain sites where each drug acts plays a surprisingly minor role in who develops substance abuse problems.

Why it matters

This confirms with objective data what interview-based studies suggested: the genetic architecture of drug abuse is mostly about general vulnerability rather than specific attraction to particular substances. This has implications for both prevention and treatment approaches.

The numbers in context

Total heritability: 64-70% across substance types; 75-90% of genetic risk was non-specific; shared environment accounted for 18-20% of variance; 76,457 sibling pairs and 2,939 twin pairs analyzed

How the study worked

Population-based study using Swedish national registries. Included 1,720 monozygotic twin pairs, 1,219 dizygotic twin pairs, and 76,457 near-age full sibling pairs. Substance abuse was identified through objective registry records rather than self-report. Structural equation modeling compared common pathway and independent pathway models.

What this study cannot tell us

Male-only sample limits generalizability to women. Registry-based ascertainment may miss less severe cases. The study examined abuse rather than use, so findings may not apply to casual or recreational patterns.

How to read the evidence

Very large population-based twin/sibling design with objective registry data, though cross-sectional and limited to males.

When this study was published

Published in 2015 using Swedish registry data. The genetic architecture of substance abuse is unlikely to have changed.

The bigger picture

If most genetic risk for substance abuse is shared across drug classes, then the biological pathways driving addiction likely involve general reward processing, impulsivity, or stress response rather than drug-specific receptor variations.

Questions still open

What specific biological pathways account for the shared genetic risk? Would women show the same pattern of non-specific genetic vulnerability? How do the substance-specific genetic factors that do exist differ across drug classes?

Common questions

Does this mean addiction is genetic?

Genetics account for 64-70% of the variation in substance abuse risk, but environment still plays a significant role (18-20% from shared environment, plus non-shared environmental factors).

If genetic risk is shared, why do people prefer different drugs?

A smaller portion (10-25%) of genetic risk is substance-specific, and environmental factors like availability, peer influence, and cultural context strongly shape which substances people encounter and use.

Read the original research

A population-based Swedish Twin and Sibling Study of cannabis, stimulant and sedative abuse in men.

Drug and alcohol dependence, 149, 49-54

View on PubMed ↗Publisher’s paper ↗

Citation

Kendler, Kenneth S; Ohlsson, Henrik; Maes, Hermine H; Sundquist, Kristina; Lichtenstein, Paul; Sundquist, Jan. (2015). A population-based Swedish Twin and Sibling Study of cannabis, stimulant and sedative abuse in men.. Drug and alcohol dependence, 149, 49-54. https://doi.org/10.1016/j.drugalcdep.2015.01.016